Clinical Trial Update: Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and QT interval study assessing the effect of the investigational agent JY09 on the PK of metformin, rosuvastatin, and digoxin in overwe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DIGOXIN (Digoxin)
• JY09
• Rosuvastatin (rosuvastatin)
• metformin (metformin)

Snippet

Sponsor: Beijing Dongfang Biotech Co., Ltd. | Conditions: Diabetes Mellitus, Type 2, Overweight | Phase 1 | Status: COMPLETED